The Landstreet Lens
Trade War: An Oxymoron
Trade War: An Oxymoron

Free trade is a tenet of free market capitalism, so a "trade war" is a contradiction in terms. Prices are rising for American consumers, the midterms are coming, and China's trade just posted its best month in five years.

Read more →
The Unaffordable Care Act
The Unaffordable Care Act

Since the Affordable Care Act passed, hospital prices have doubled. And the bill is still arriving: ACA insurers in Washington, New York, Rhode Island, and Oregon are asking for 25–28% rate hikes for 2027 — New York's up from 3% a year ago. When government becomes the biggest customer in a market, prices stop responding to productivity and start responding to policy.

Read more →
Help Wanted: Government Statisticians
Help Wanted: Government Statisticians

Of the 57,000 jobs added in June, 47,000 came from health care and social assistance — and the BLS has revised its own payroll figures lower in 30 of the last 41 months. The bottom line: the labor market is weaker than the headline suggests, and the headline itself keeps getting revised away.

Read more →

The Landstreet Lens

Entertaining commentary on data from the U.S. economy, capital markets, and government policy.

Disclosures:

The content of The Landstreet Lens may not be distributed, transmitted, or otherwise communicated to others, in whole or in part, without the express consent of N3L Capital Partners (together with its affiliates, "N3L").

Unless otherwise noted, information included herein is presented as of the dates indicated. N3L makes no representation or warranty, expressed or implied, with respect to the accuracy, reasonableness, or completeness of any of the information contained herein, including, but not limited to, information obtained from third parties or government sources, which is subject to revision by the source agency. Opinions, estimates, and projections constitute the current judgment of the author as of the date indicated. They do not necessarily reflect the views and opinions of N3L and are subject to change at any time without notice. N3L does not have any responsibility to update the information to account for such changes. There can be no assurance that any trends discussed herein will continue.

Nothing herein constitutes an offer to sell, or the solicitation of an offer to buy, any security, product, or service, including any interest in any investment product or fund managed or advised by N3L. Investments in a private fund can be made only pursuant to such fund's subscription documents and private placement memorandum and only after careful consideration of the risk factors set forth therein. Investments entail significant risks and are suitable only for certain investors as part of an overall diversified investment strategy and only for investors able to withstand a total loss of investment. Past performance is no guarantee of future results.

Certain statements herein may be "forward-looking" in nature. Due to various risks and uncertainties, actual events or results may differ materially from those reflected or contemplated in such forward-looking statements, and undue reliance should not be placed on them. Forward-looking statements may be identified by terminology such as "may," "will," "should," "expect," "anticipate," "project," "estimate," "intend," "continue," or "believe," or the negatives or other variations thereof.

N3L and its affiliates may hold positions in securities, instruments, or asset classes discussed herein.